A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to investigate the potential benefits/risks regarding
pretreatment with prasugrel in non-ST-elevation myocardial infarction (NSTEMI) participants
with elevated troponin scheduled for coronary angiography/percutaneous coronary intervention
(PCI).